Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | |
| Cash Flows From Operating Activities | |
| Net Income | -119,424 |
| Depreciation Amortization | 221 |
| Other Working Capital | -436 |
| Other Operating Activity | 94,020 |
| Operating Cash Flow | $-25,619 |
| Cash Flows From Investing Activities | |
| PPE Investments | -2,292 |
| Other Investing Activity | 2,742 |
| Investing Cash Flow | $450 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 140,809 |
| Financing Cash Flow | $140,809 |
| Exchange Rate Effect | -8,190 |
| Beginning Cash Position | 47,353 |
| End Cash Position | 154,803 |
| Net Cash Flow | $107,450 |
| Free Cash Flow | |
| Operating Cash Flow | -25,619 |
| Free Cash Flow | -25,619 |